PTC Therapeutics, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
PTC Therapeutics, Inc. (PTCT) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$31.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-30
- PTC Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $37.50M.
- PTC Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$68.71M, a 471.38% decline year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $108.08M.
- PTC Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$43.20M, a 336.29% decline year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $71.74M.
- PTC Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$33.32M, a 168.92% decline from fiscal 2023.
- PTC Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $48.35M, a 75.54% increase from fiscal 2022.
- PTC Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $27.54M, a 39.68% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $37.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$31.21M 10-Q · filed 2026-07-30 | $76.87M derived: sum of 3 quarters · filed 2026-07-30 | $33.66M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | -$68.71M 10-Q · filed 2026-05-07 | $39.37M derived: sum of 2 quarters · filed 2026-05-07 | -$3.84M derived: sum of 3 quarters · filed 2026-05-07 | -$15.47M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $108.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $64.88M derived: sum of 2 quarters · filed 2026-02-19 | $53.24M derived: sum of 3 quarters · filed 2026-07-30 | $71.74M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | -$43.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$54.84M derived: sum of 2 quarters · filed 2026-07-30 | -$36.34M 10-Q · filed 2025-11-04 | -$69.25M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | -$11.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $6.86M 10-Q · filed 2026-07-30 | -$26.04M derived: sum of 3 quarters · filed 2026-07-30 | -$7.76M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $18.50M 10-Q · filed 2026-05-07 | -$14.40M derived: sum of 2 quarters · filed 2026-05-07 | $3.88M derived: sum of 3 quarters · filed 2026-05-07 | -$9.43M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$32.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$14.62M derived: sum of 2 quarters · filed 2026-02-19 | -$27.93M derived: sum of 3 quarters · filed 2026-02-19 | -$33.32M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $18.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.97M derived: sum of 2 quarters · filed 2025-11-04 | -$417.00K 10-Q · filed 2025-11-04 | $7.50M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | -$13.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$18.70M 10-Q · filed 2025-08-07 | -$10.79M derived: sum of 3 quarters · filed 2026-02-19 | -$2.79M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | -$5.39M 10-Q · filed 2025-05-06 | $2.52M derived: sum of 2 quarters · filed 2026-02-19 | $10.52M derived: sum of 3 quarters · filed 2026-02-19 | $9.43M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $7.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $15.91M derived: sum of 2 quarters · filed 2026-02-19 | $14.82M derived: sum of 3 quarters · filed 2026-02-19 | $48.35M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.91M derived: sum of 2 quarters · filed 2024-11-07 | $40.43M 10-Q · filed 2024-11-07 | $66.41M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $32.44M 10-Q · filed 2024-08-08 | $58.41M derived: sum of 3 quarters · filed 2025-02-27 | $69.04M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $33.52M 10-Q · filed 2024-04-25 | $59.50M derived: sum of 2 quarters · filed 2025-02-27 | $70.13M derived: sum of 3 quarters · filed 2025-02-27 | $91.75M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $25.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $36.60M derived: sum of 2 quarters · filed 2025-02-27 | $58.22M derived: sum of 3 quarters · filed 2025-02-27 | $27.54M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $10.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $32.25M derived: sum of 2 quarters · filed 2023-10-26 | $1.57M 10-Q · filed 2023-10-26 | $38.34M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $21.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$9.06M 10-Q · filed 2023-08-03 | $27.71M derived: sum of 3 quarters · filed 2024-02-29 | $45.82M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | -$30.68M 10-Q · filed 2023-04-27 | $6.09M derived: sum of 2 quarters · filed 2024-02-29 | $24.20M derived: sum of 3 quarters · filed 2024-02-29 | $43.73M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $36.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $54.88M derived: sum of 2 quarters · filed 2024-02-29 | $74.42M derived: sum of 3 quarters · filed 2024-02-29 | $45.66M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $18.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $37.64M derived: sum of 2 quarters · filed 2022-10-27 | $8.89M 10-Q · filed 2022-10-27 | $26.46M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-06-30 | $19.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$9.22M 10-Q · filed 2022-08-04 | $8.35M derived: sum of 3 quarters · filed 2023-02-21 | $70.24M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-03-31 | -$28.76M 10-Q · filed 2022-05-03 | -$11.18M derived: sum of 2 quarters · filed 2023-02-21 | $50.70M derived: sum of 3 quarters · filed 2023-02-21 | $47.21M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2020-12-31 | $17.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $79.46M derived: sum of 2 quarters · filed 2023-02-21 | $75.96M derived: sum of 3 quarters · filed 2023-02-21 | $71.96M 10-K · filed 2023-02-21 | $70.80M 10-K · filed 2021-02-25 | ||
| 2020-09-30 | $61.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $58.39M derived: sum of 2 quarters · filed 2021-10-28 | $54.39M 10-Q · filed 2021-10-28 | $80.53M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | -$3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$7.50M 10-Q · filed 2021-07-29 | $18.64M derived: sum of 3 quarters · filed 2022-02-22 | $26.89M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | -$4.00M 10-Q · filed 2021-05-04 | $22.14M derived: sum of 2 quarters · filed 2022-02-22 | $30.38M derived: sum of 3 quarters · filed 2022-02-22 | $51.49M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $26.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $34.38M derived: sum of 2 quarters · filed 2022-02-22 | $55.49M derived: sum of 3 quarters · filed 2022-02-22 | $26.84M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $8.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $29.35M derived: sum of 2 quarters · filed 2020-10-29 | $695.00K 10-Q · filed 2020-10-29 | $25.97M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $21.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$7.55M 10-Q · filed 2020-08-05 | $17.73M derived: sum of 3 quarters · filed 2021-02-25 | $34.11M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | -$28.65M 10-Q · filed 2020-04-30 | -$3.38M derived: sum of 2 quarters · filed 2021-02-25 | $13.00M derived: sum of 3 quarters · filed 2021-02-25 | $22.03M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $25.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $41.65M derived: sum of 2 quarters · filed 2021-02-25 | $50.69M derived: sum of 3 quarters · filed 2021-02-25 | $43.88M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $16.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $25.42M derived: sum of 2 quarters · filed 2019-10-30 | $18.61M 10-Q · filed 2019-10-30 | $30.81M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $9.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.23M 10-Q · filed 2019-08-06 | $14.43M derived: sum of 3 quarters · filed 2020-03-02 | $13.78M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | -$6.81M 10-Q · filed 2019-05-02 | $5.39M derived: sum of 2 quarters · filed 2020-03-02 | $4.75M derived: sum of 3 quarters · filed 2020-03-02 | $21.12M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $12.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $11.56M derived: sum of 2 quarters · filed 2020-03-02 | $27.93M derived: sum of 3 quarters · filed 2020-03-02 | $24.01M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | -$645.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $15.73M derived: sum of 2 quarters · filed 2018-11-05 | $11.81M 10-Q · filed 2018-11-05 | $13.99M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $16.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $12.45M 10-Q · filed 2018-08-07 | $14.63M derived: sum of 3 quarters · filed 2019-03-01 | $20.15M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | -$3.92M 10-Q · filed 2018-05-09 | -$1.74M derived: sum of 2 quarters · filed 2019-03-01 | $3.77M derived: sum of 3 quarters · filed 2019-03-01 | $2.79M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $7.69M derived: sum of 2 quarters · filed 2019-03-01 | $6.71M derived: sum of 3 quarters · filed 2019-03-01 | $4.26M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $4.53M derived: sum of 2 quarters · filed 2017-11-02 | $2.08M 10-Q · filed 2017-11-02 | $16.19M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | -$983.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$3.44M 10-Q · filed 2017-08-09 | $10.68M derived: sum of 3 quarters · filed 2018-03-06 | $19.59M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | -$2.45M 10-Q · filed 2017-05-08 | $11.66M derived: sum of 2 quarters · filed 2018-03-06 | $20.57M derived: sum of 3 quarters · filed 2018-03-06 | $20.12M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | $14.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $23.02M derived: sum of 2 quarters · filed 2018-03-06 | $22.57M derived: sum of 3 quarters · filed 2018-03-06 | $16.98M 10-K · filed 2018-03-06 | |||
| 2015-09-30 | $8.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $8.46M derived: sum of 2 quarters · filed 2016-11-03 | $2.87M 10-Q · filed 2016-11-03 | $15.50M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | -$450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$6.04M 10-Q · filed 2016-08-04 | $6.59M derived: sum of 3 quarters · filed 2017-03-16 | $11.74M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | -$5.59M 10-Q · filed 2016-05-05 | $7.04M derived: sum of 2 quarters · filed 2017-03-16 | $12.19M derived: sum of 3 quarters · filed 2017-03-16 | $14.80M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $17.78M derived: sum of 2 quarters · filed 2017-03-16 | $20.39M derived: sum of 3 quarters · filed 2017-03-16 | $16.91M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $5.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $7.76M derived: sum of 2 quarters · filed 2015-11-09 | $4.29M 10-Q · filed 2015-11-09 | $6.29M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$866.00K 10-Q · filed 2015-07-31 | $1.14M derived: sum of 3 quarters · filed 2016-02-29 | $1.28M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$3.47M 10-Q · filed 2015-05-05 | -$1.47M derived: sum of 2 quarters · filed 2016-02-29 | -$1.32M derived: sum of 3 quarters · filed 2016-02-29 | -$2.73M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.15M derived: sum of 2 quarters · filed 2016-02-29 | $737.00K derived: sum of 3 quarters · filed 2016-02-29 | $5.18M 10-K · filed 2016-02-29 | $5.18M 10-K · filed 2014-03-06 | ||
| 2013-09-30 | $146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$1.26M derived: sum of 2 quarters · filed 2014-11-06 | $3.18M 10-Q · filed 2014-11-06 | $3.18M 10-Q · filed 2013-11-14 | $1.90M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | -$1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $3.04M 10-Q · filed 2014-08-07 | $3.03M 10-Q · filed 2013-08-13 | $1.76M derived: sum of 3 quarters · filed 2015-03-02 | $1.08M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $4.45M 10-Q · filed 2014-05-06 | $3.17M derived: sum of 2 quarters · filed 2015-03-02 | $2.49M derived: sum of 3 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$1.95M derived: sum of 2 quarters · filed 2015-03-02 | -$6.03M 10-K · filed 2015-03-02 | -$6.03M 10-K · filed 2014-03-06 | |||
| 2012-09-30 | -$675.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$4.75M 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$4.07M 10-Q · filed 2013-08-13 | ||||||
| 2011-12-31 | -$3.16M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |